Status:
RECRUITING
Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication
Lead Sponsor:
Chad Stecher@asu.edu
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Wellth Inc.
Conditions:
Medication Adherence
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to determine the effectiveness of a novel mobile health-based habit formation intervention for increasing and maintaining adherence to anti-hypertensive (AH) medicat...
Eligibility Criteria
Inclusion
- Eligibility Criteria:
- Aged 18 years or older
- Currently diagnosed with hypertension (either stage I or stage II hypertension)
- Able to read/write/understand English
- Have daily access to a smartphone
- Engaged in hypertension care: Already been prescribed hypertension medication for a minimum of 12 months at the time of study enrollment
- Demonstrated AH medication nonadherence by having over 73 days without documented AH medication prescription coverage (observable in Arizona Health Care Cost Containment System (AHCCCS) prescription drugs claims) in the past 12 months (i.e. \<80% mean adherence)
Exclusion
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2029
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06876233
Start Date
September 1 2025
End Date
March 30 2029
Last Update
December 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wellth Inc.
Los Angeles, California, United States, 90292